Investigación en Enfermidades Hematolóxicas
University of California, San Francisco
San Francisco, Estados UnidosPublications in collaboration with researchers from University of California, San Francisco (1)
2023
-
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
Journal of Thrombosis and Haemostasis